Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves new pain medicine
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
BioPharma Dive
5h
A new, non-opioid pain drug is here. Getting it to patients could be agony.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
Psychology Today
4h
Treating Pain—Avoiding the Brain
A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Black boxes recovered
New tariffs coming Saturday
IL won’t hire Jan. 6 rioters
To again run for Senate?
Todd exits NBC News
Apologizes for old tweets
Tour boat captain sentenced
Cancerous tumor removed
Activists call for boycott
Cause of death revealed
Granted legal personhood
Navajo men, partner indicted
Top leaders asked to resign
Recuses self from Act 10 suit
Inmate's transfer blocked
Olympic gold medalist dies
Confirmed interior secretary
Hamas confirms death
To raise hourly pay
'As Tears Go By' singer dies
US inflation ticked higher
S3 release date revealed
Ground stop amid IT outage
Seeking a new trial
FDA approves painkiller
Weekly jobless claims fall
DOJ sues to block deal
Nashville bids for franchise
Shiffrin finishes 10th
Partners w/ US national labs
Michigan priest loses license
Feedback